Analystreport

Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target raised by analysts at Stephens from $17.00 to $24.00.

Myriad Genetics, Inc.  (MYGN) 
Last myriad genetics, inc. earnings: 2/6 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: myriad.com/news-center/investor-information